Cargando…
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling
Recent evidence has shown that the induction of ferroptosis is a new therapeutic strategy for advanced prostate cancer (PCa) when used as a monotherapy or in combination with second-generation antiandrogens. However, whether ferroptosis inducers are effective against docetaxel-resistant PCa remains...
Autores principales: | Jiang, Xingkang, Guo, Shanqi, Xu, Mengyao, Ma, Baojie, Liu, Ranlu, Xu, Yong, Zhang, Yangyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985761/ https://www.ncbi.nlm.nih.gov/pubmed/35402284 http://dx.doi.org/10.3389/fonc.2022.862015 |
Ejemplares similares
-
The Role of lncRNA PCAT6 in Cancers
por: Wang, Siying, et al.
Publicado: (2021) -
LncRNA PCAT-1 in gastrointestinal cancers: A meta-analysis
por: Liu, Wanwei, et al.
Publicado: (2018) -
Inhibition of lncRNA PCAT19 promotes breast cancer proliferation
por: Feng, Jianyuan, et al.
Publicado: (2023) -
Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis
por: Potts, Margaret A., et al.
Publicado: (2023) -
LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
por: Gao, Yanping, et al.
Publicado: (2022)